Quantitative Investment Management LLC increased its holdings in shares of SPDR S&P Biotech (NYSEARCA:XBI) by 642.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,451,998 shares of the exchange traded fund’s stock after purchasing an additional 1,256,398 shares during the quarter. SPDR S&P Biotech accounts for 1.7% of Quantitative Investment Management LLC’s portfolio, making the stock its 5th biggest holding. Quantitative Investment Management LLC’s holdings in SPDR S&P Biotech were worth $112,065,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Newman Dignan & Sheerar Inc. lifted its holdings in shares of SPDR S&P Biotech by 0.6% during the second quarter. Newman Dignan & Sheerar Inc. now owns 8,260 shares of the exchange traded fund’s stock valued at $638,000 after purchasing an additional 50 shares in the last quarter. Cornerstone Advisory LLP lifted its holdings in shares of SPDR S&P Biotech by 109.0% during the second quarter. Cornerstone Advisory LLP now owns 14,628 shares of the exchange traded fund’s stock valued at $1,129,000 after purchasing an additional 7,628 shares in the last quarter. FineMark National Bank & Trust lifted its holdings in shares of SPDR S&P Biotech by 7.4% during the second quarter. FineMark National Bank & Trust now owns 5,210 shares of the exchange traded fund’s stock valued at $402,000 after purchasing an additional 360 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of SPDR S&P Biotech by 14.0% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 26,186 shares of the exchange traded fund’s stock valued at $2,021,000 after purchasing an additional 3,212 shares in the last quarter. Finally, Janney Montgomery Scott LLC lifted its holdings in shares of SPDR S&P Biotech by 10.9% during the second quarter. Janney Montgomery Scott LLC now owns 98,057 shares of the exchange traded fund’s stock valued at $7,568,000 after purchasing an additional 9,655 shares in the last quarter.

ILLEGAL ACTIVITY WARNING: “SPDR S&P Biotech (XBI) Stake Lifted by Quantitative Investment Management LLC” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/19/spdr-sp-biotech-xbi-stake-lifted-by-quantitative-investment-management-llc.html.

Shares of SPDR S&P Biotech (XBI) traded down 0.58% on Tuesday, hitting $83.54. The stock had a trading volume of 913,836 shares. SPDR S&P Biotech has a 12 month low of $53.15 and a 12 month high of $84.90. The company’s 50 day moving average price is $79.59 and its 200-day moving average price is $74.14.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Monday, September 18th will be given a $0.037 dividend. The ex-dividend date of this dividend is Friday, September 15th. This represents a $0.15 dividend on an annualized basis and a dividend yield of 0.18%.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Stock Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related stocks with our FREE daily email newsletter.